Fluorescence Imaging With Indocyanine Green(ICG) in Endoscopic Spinal Surgery

• Status: Not yet recruiting
• Trial end date: 2024-12-01
• Target enrollment: 0
• Participant gender: All

Summary

In endoscopic spinal nerve root decompression surgery, the intraoperative nerve exploration is time-consuming and critical. According to statistics, the incidence of nerve root injury under spinal endoscope is 1.8-2.5%. Damage to nerve roots may lead to postoperative sensory retardation and motor weakness, thereby impairing the physical function of patients. A real-time auxiliary intraoperative nerve identification technology is necessary.

In this prospective, open-label, randomized, parallel controlled trial, 40 patients who undergo endoscopic spinal surgery are included. Subjects are randomly divided into control group and low, medium and high Indocyanine green(ICG) preoperative administration experimental group. Standard endoscopic spinal surgery is performed in the control group. Patients in the experimental group received an intravenous injection of ICG before surgery, and a standard endoscopic spinal surgery is performed with the use of a fluoroscopic endoscopic surgical imaging system to assist the surgeon in identifying and protecting the nerve roots.

The main objectives of this experiment are (i) to explore the safety and feasibility of ICG fluorescence imaging to assist in nerve root identification during endoscopic spinal surgery and (ii) the effectiveness of this technique for endoscopic search for nerve roots. The secondary objective is to explore the optimal ICG dosing regimen.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Zhongnan Hospital

Criteria

Inclusion Criteria:

• Patients diagnosed with lumbar disc herniation based on symptoms and Imaging examination

• Patients undergo endoscopy spinal surgery for nerve root decompression

• Patients have no clear contraindications to surgery, and has the ability to understand and act and has informed consent, and can participate in all study follow-up voluntarily and signe a written informed consent form.

Exclusion Criteria:

• The patients have thyroid related diseases, including autonomous nodules

• Patients are allergic to iodine or shellfish

• Patients have ankylosing spondylitis, lumbar instability or bony spinal stenosis

• Patients have diabetes, vascular related diseases, or abnormal liver and kidney function

• Difficulty in tolerating anaesthesia

• Pregnant or lactating women

• Patients are unable to communicate or do not follow directions

• The investigators consider the patient unsuitable to participate in this study